Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-cell recovery. Radiol Oncol [Internet]. 2026 Mar. 26 [cited 2026 Jul. 28];60(1):76-85. Available from: https://www.ojstest.computing.si/index.php/ro/article/view/4845